4887.T
SAWAI GROUP HOLDINGS Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 1,661.50
+2.18%Sep 18, 2026, 02:00 UTC
Sawai Pharmaceutical and Towa Pharmaceutical, the two major generic drugmakers under Sawai Group Holdings, are increasing production and supply of the anti-influenza generic oseltamivir in response to an unusually early flu season.
Source:Aug 6, 2026, 10:42 UTC
Sawai Pharmaceutical, under Sawai Group Holdings, will discontinue 46 generic drug products as inventory runs out, including 39 due to a major product portfolio restructuring to improve production efficiency and ensure stable supply of generics.
Source: